Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral pyridostigmine for postoperative ileus after elective colorectal surgery
ACTRN12620001262998Phase 2Recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pyridostigmine in postoperative ileus (POI), sponsored by Royal Adelaide Hospital. Primary endpoints: 30-day postoperative complication rate, Duration of postoperative ileus and 1 more. Started Sep 2020; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ACTRN12620001262998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001262998.